-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
By screening the genomes of more than 12,000 tumors for hundreds of millions of hidden mutations, researchers have uncovered patterns of DNA changes that could provide clues to the genetic and environmental causes of cancer
The study, published April 21 in the journal Science , is the largest of its kind
Massive genetic screening effort helps pinpoint root causes of breast cancer
Size matters for these analyses, says Núria López-Bigas, a computational cancer biologist at the Institute for Biomedical Research in Barcelona, Spain
Mutant footprint
A single cancer cell may contain hundreds of thousands of mutations, sometimes more than a million, but only a few of them lead directly to tumor development
Many of the remaining "bystander" mutations can also be informative
These mutational patterns can be likened to footprints in the sand, said Serena Nik-Zainal, a computational biologist at the University of Cambridge, UK, and co-author of the Science
The largest previously reported study on mutational signatures, published in 2020, analyzed approximately 5,000 whole-genome sequences from tumor samples collected in an international effort
Cancer 'moonshot' has new ambitious goal: to halve deaths in 25 years
In the new study, the team analysed more than 12,000 cancer genomes collected by the UK NHS as part of the UK Genomics UK 100,000 Genomes Project
The study, which included samples from 19 tumor types, yielded dozens of previously unknown mutational footprints, some of which could be traced to defects in specific cellular methods of repairing DNA
Dávid Szüts, a cancer biologist at the Centre for Natural Sciences in Budapest, says researchers may have now identified all of the most common mutational signatures
In addition to looking for further mutational signatures, Degasperi hopes to track down more mysterious origins that have not yet been linked to oncogenic events
It is hoped that these studies will eventually lead to individual cancer treatments